Quadrant Capital Group LLC Sorrento Therapeutics, Inc. Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.74 - $1.83 $3,620 - $8,952
4,892 Added 216.27%
7,154 $6,000
Q2 2022

Aug 09, 2022
SELL
$1.24 - $2.33 $250 - $470
-202 Reduced 8.2%
2,262 $5,000
Q1 2022

May 06, 2022
BUY
$2.0 - $4.9 $404 - $989
202 Added 8.93%
2,464 $6,000
Q4 2020

Feb 16, 2021
BUY
$5.76 - $11.95 $9,872 - $20,482
1,714 Added 312.77%
2,262 $15,000
Q3 2020

Nov 13, 2020
BUY
$6.17 - $18.82 $3,381 - $10,313
548 New
548 $6,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email